Bradmer Pharmaceuticals (TSE:GLX – Get Free Report) will be posting its quarterly earnings results before the market opens on Tuesday, May 14th.
Bradmer Pharmaceuticals (TSE:GLX – Get Free Report) last issued its quarterly earnings results on Tuesday, March 26th. The company reported C$0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C$0.74 by C($0.68).
Bradmer Pharmaceuticals Price Performance
Analyst Ratings Changes
Separately, Stifel Canada reiterated a “buy” rating on shares of Bradmer Pharmaceuticals in a research report on Wednesday, March 13th.
Featured Articles
- Five stocks we like better than Bradmer Pharmaceuticals
- P/E Ratio Calculation: How to Assess Stocks
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Most Volatile Stocks, What Investors Need to Know
- 3 Value Stocks You Can Buy Before They Become Big
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Bradmer Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bradmer Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
